SLC2A1 and hepatocellular carcinoma: It was inconsistent with the previous finding that LINC00174 promotes glioma progression via miR-152-3p/SLC2A1 axis [18] and that LINC00174 plays an oncogenic role in hepatocellular carcinoma [19].